INDGN
INDEGENE LIMITED
Healthcare · Health Information Services
Market price data is delayed by at least 15 minutes. Not for trading or investment decisions.
Fundamentals
Current Price
₹490.25
P/B Ratio
4.1
52W High
₹632.9
52W Low
₹414
Dividend Yield
41.00%
Profit Margin
13.46%
ROE
—
Debt / Equity
0.04
Sector
Healthcare
Industry
Health Information Services
Peer Comparison same NSE industry · top 10 by 1M return
Medical Equipment Supplies Accessoriesas of 8 Apr 2026 close
| Symbol | Company | Price | P/B | RSI | 1M Ret | ROE | D/E |
|---|---|---|---|---|---|---|---|
| INDGNyou | Indegene Limited | ₹483.15 | 4.04 | 63.2 | +6.9% | — | 0.04 |
| POLYMED | Poly Medicure Limited | ₹1,440.4 | 5.00 | 65.8 | +9.2% | — | 0.08 |
| AARTIPHARM | Aarti Pharmalabs Limited | ₹688.25 | 3.05 | 62.8 | +1.1% | — | 0.33 |
| NURECA | Nureca Limited | ₹255.3 | 1.48 | 53.8 | -2.8% | — | 0.03 |
Price Chart
Quarterly Results Last 4 quarters
| Metric | 2025-12 | 2025-06 | 2025-03 | 2024-12 |
|---|---|---|---|---|
| Revenue | ₹942.1 Cr | ₹760.8 Cr | ₹755.6 Cr | ₹720.4 Cr |
| Operating Income | ₹119.9 Cr | ₹133.7 Cr | ₹126.8 Cr | ₹111.8 Cr |
| Net Income | ₹102.9 Cr | ₹116.4 Cr | ₹117.6 Cr | ₹109.7 Cr |
Values in INR Crore. Source: yfinance / NSE filings.
SWOT Analysis AI · news + fundamentals
SWOT not available.
Recent News Sentiment
No recent news for this stock.
Data sourced from yfinance and public NSE filings. Not investment advice.